Cargando…
Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival
Galectin-1 (GAL1) is a β-galactoside-binding protein involved in multiple aspects of tumorigenesis. However, the biological role of GAL1 in upper tract urothelial carcinoma (UTUC) has not been entirely understood. Herein, we investigated the oncological effects of GAL1 expression in tumor specimens...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226470/ https://www.ncbi.nlm.nih.gov/pubmed/32225123 http://dx.doi.org/10.3390/cells9040806 |
_version_ | 1783534295651975168 |
---|---|
author | Su, Yu-Li Luo, Hao-Lun Huang, Chun-Chieh Liu, Ting-Ting Huang, Eng-Yen Sung, Ming-Tse Lin, Jen-Jie Chiang, Po-Hui Chen, Yen-Ta Kang, Chih-Hsiung Cheng, Yuan-Tso |
author_facet | Su, Yu-Li Luo, Hao-Lun Huang, Chun-Chieh Liu, Ting-Ting Huang, Eng-Yen Sung, Ming-Tse Lin, Jen-Jie Chiang, Po-Hui Chen, Yen-Ta Kang, Chih-Hsiung Cheng, Yuan-Tso |
author_sort | Su, Yu-Li |
collection | PubMed |
description | Galectin-1 (GAL1) is a β-galactoside-binding protein involved in multiple aspects of tumorigenesis. However, the biological role of GAL1 in upper tract urothelial carcinoma (UTUC) has not been entirely understood. Herein, we investigated the oncological effects of GAL1 expression in tumor specimens and identified related gene alterations through molecular analysis of GAL1. Clinical parameter data and tumor specimens were collected from 86 patients with pT3N0M0 UTUC who had undergone radical nephroureterectomy. We analyzed the difference in survival by using Kaplan–Meier analyses and Cox proportional regression models and in GAL1 expression by using immunohistochemical (IHC) methods. Public genomic data from the Cancer Genome Atlas (TCGA) and GSE32894 data sets were analyzed for comparison. Using four urothelial carcinoma (UC) cell lines (BFTC-909, T24, RT4, and J82) as in vitro models, we evaluated the functions of GAL1 in UC cell growth, invasiveness, and migration and its role in downstream signaling pathways. The study population was classified into two groups, GAL1-high (n = 35) and GAL1-low (GAL1 n = 51), according to IHC interpretation. Univariate analysis revealed that high GAL1 expression was significantly associated with poor recurrence-free survival (RFS; p = 0.028) and low cancer-specific survival (CSS; p = 0.025). Multivariate analysis revealed that GAL1-high was an independent predictive factor for RFS (hazard ratio (HR) 2.43; 95% confidence interval (CI) 1.17–5.05, p = 0.018) and CSS (HR 4.04; 95% CI 1.25–13.03, p = 0.019). In vitro studies revealed that GAL1 knockdown significantly reduced migration and invasiveness in UTUC (BFTC-909) and bladder cancer cells (T24). GAL1 knockdown significantly reduced protein levels of matrix metalloproteinase-2 (MMP-2) and MMP-9, which increased tissue inhibitor of metalloproteinase-1 (TIMP-1) and promoted epithelial–mesenchymal transition (EMT). Through gene expression microarray analysis of GAL1 vector and GAL1-KD cells, we identified multiple significant signaling pathways including p53, Forkhead box O (FOXO), and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT). We validated microarray results through immunoblotting, thus proving that downregulation of GAL1 reduced focal adhesion kinase (FAK), p-PI3K, p-AKT, and p-mTOR expression. We concluded that GAL1 expression was highly related to oncological survival in patients with locally advanced UTUC. GAL1 promoted UC invasion and metastasis by activating the FAK/PI3K/AKT/mTOR pathway. |
format | Online Article Text |
id | pubmed-7226470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72264702020-05-18 Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival Su, Yu-Li Luo, Hao-Lun Huang, Chun-Chieh Liu, Ting-Ting Huang, Eng-Yen Sung, Ming-Tse Lin, Jen-Jie Chiang, Po-Hui Chen, Yen-Ta Kang, Chih-Hsiung Cheng, Yuan-Tso Cells Article Galectin-1 (GAL1) is a β-galactoside-binding protein involved in multiple aspects of tumorigenesis. However, the biological role of GAL1 in upper tract urothelial carcinoma (UTUC) has not been entirely understood. Herein, we investigated the oncological effects of GAL1 expression in tumor specimens and identified related gene alterations through molecular analysis of GAL1. Clinical parameter data and tumor specimens were collected from 86 patients with pT3N0M0 UTUC who had undergone radical nephroureterectomy. We analyzed the difference in survival by using Kaplan–Meier analyses and Cox proportional regression models and in GAL1 expression by using immunohistochemical (IHC) methods. Public genomic data from the Cancer Genome Atlas (TCGA) and GSE32894 data sets were analyzed for comparison. Using four urothelial carcinoma (UC) cell lines (BFTC-909, T24, RT4, and J82) as in vitro models, we evaluated the functions of GAL1 in UC cell growth, invasiveness, and migration and its role in downstream signaling pathways. The study population was classified into two groups, GAL1-high (n = 35) and GAL1-low (GAL1 n = 51), according to IHC interpretation. Univariate analysis revealed that high GAL1 expression was significantly associated with poor recurrence-free survival (RFS; p = 0.028) and low cancer-specific survival (CSS; p = 0.025). Multivariate analysis revealed that GAL1-high was an independent predictive factor for RFS (hazard ratio (HR) 2.43; 95% confidence interval (CI) 1.17–5.05, p = 0.018) and CSS (HR 4.04; 95% CI 1.25–13.03, p = 0.019). In vitro studies revealed that GAL1 knockdown significantly reduced migration and invasiveness in UTUC (BFTC-909) and bladder cancer cells (T24). GAL1 knockdown significantly reduced protein levels of matrix metalloproteinase-2 (MMP-2) and MMP-9, which increased tissue inhibitor of metalloproteinase-1 (TIMP-1) and promoted epithelial–mesenchymal transition (EMT). Through gene expression microarray analysis of GAL1 vector and GAL1-KD cells, we identified multiple significant signaling pathways including p53, Forkhead box O (FOXO), and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT). We validated microarray results through immunoblotting, thus proving that downregulation of GAL1 reduced focal adhesion kinase (FAK), p-PI3K, p-AKT, and p-mTOR expression. We concluded that GAL1 expression was highly related to oncological survival in patients with locally advanced UTUC. GAL1 promoted UC invasion and metastasis by activating the FAK/PI3K/AKT/mTOR pathway. MDPI 2020-03-26 /pmc/articles/PMC7226470/ /pubmed/32225123 http://dx.doi.org/10.3390/cells9040806 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Su, Yu-Li Luo, Hao-Lun Huang, Chun-Chieh Liu, Ting-Ting Huang, Eng-Yen Sung, Ming-Tse Lin, Jen-Jie Chiang, Po-Hui Chen, Yen-Ta Kang, Chih-Hsiung Cheng, Yuan-Tso Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival |
title | Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival |
title_full | Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival |
title_fullStr | Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival |
title_full_unstemmed | Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival |
title_short | Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival |
title_sort | galectin-1 overexpression activates the fak/pi3k/akt/mtor pathway and is correlated with upper urinary urothelial carcinoma progression and survival |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226470/ https://www.ncbi.nlm.nih.gov/pubmed/32225123 http://dx.doi.org/10.3390/cells9040806 |
work_keys_str_mv | AT suyuli galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT luohaolun galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT huangchunchieh galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT liutingting galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT huangengyen galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT sungmingtse galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT linjenjie galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT chiangpohui galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT chenyenta galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT kangchihhsiung galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival AT chengyuantso galectin1overexpressionactivatesthefakpi3kaktmtorpathwayandiscorrelatedwithupperurinaryurothelialcarcinomaprogressionandsurvival |